Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

Granules India confirms $35m US plant expansion will create jobs

24-May-2017 - Granules India says adding manufacturing capacity at its facility in Virginia, US will create 102 jobs.

Eye drops to replace painful injections in AMD patients

24-May-2017 - The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.

Aduro and Merck & Co to test Keytruda and CRS-207 in second cancer study

22-May-2017 - Merck & Co and Aduro Biotech have announced plans to test Keytruda combined with CRS-207 in patients suffering malignant pleural mesothelioma as a result of exposure to asbestos.

Russia clears Saneca Pharma to supply dosage forms made at Slovakian site

16-May-2017 - Russian Regulators have issued Saneca Pharma with a cGMP certificate after inspecting its facility in Hlohovec, Slovakia.

Coming to America: Evolving pharma landscape brings CPhI to Philadelphia

16-May-2017 - With almost 40% of attendees coming from outside the US, the political climate has had no effect on the latest CPhI franchise which starts today in Philadelphia.

News in brief

Thermo Fisher Scientific Inc to buy Patheon NV for $7.2bn

15-May-2017 - Thermo Fisher Scientific Inc has announced its intention to buy Patheon NV in a deal agreed by both firms’ boards.

Dr Reddy's: No production halt at Bachupally plant hit with Form 483

02-May-2017 - The US FDA has identified problems at Dr Reddy’s generic drug manufacturing site in Bachupally, India according to a filing on the Bombay Stock Exchange (BSE).

MPP to make hep C drug affordable for low and middle income countries

26-Apr-2017 - Pharco Pharmaceuticals has granted a license to make, sell and export the hepatitis C drug ravidasvir (RAV) to Medicines Patent Pool (MPP). 

LabCorp to relocate and expand UK CMC business

25-Apr-2017 - LabCorp will relocate its UK CMC services unit to a larger site and has said it is confident the Government will maintain its commitment to the drug industry after Brexit.

Partnering key to deliver next-gen drug delivery tech, say industry experts

19-Apr-2017 - Partnering and collaborating to advance drug delivery innovation  is essential, now more than ever, say industry experts from Boehringer-Ingelheim and Merck.

Aurobindo Pharma gets Form 483 from US FDA after Bachupally inspection

19-Apr-2017 - The US FDA completed an inspection of Aurobindo Pharma Limited’s manufacturing plant in Bachupally, Hyderabad yesterday, issuing the Indian drug firm with a Form 483 detailing six observations.

Cadila and Arecor team to develop longer-acting insulin glargine

13-Apr-2017 - Arecor has entered a £45m ($56m) agreement to develop once daily injection of Cadila Pharmaceuticals’ basal insulin product using its reformulation technology.

Teva's Austedo is first 'heavy hydrogen' drug to win US FDA approval

12-Apr-2017 - The US FDA has approved its first deuterated drug, clearing Teva’s Austedo (deutetrabenazine) for Huntington’s disease-related movement disorders.

News in brief

Fresenius Kabi in talks to buy Akorn

10-Apr-2017 - Akorn Inc is in takeover talks with German injectable drug specialist Fresenius SE & Co. KGaA.

Ferring teams up with Alrise in latest drug delivery tech deal

10-Apr-2017 - Ferring Pharmaceuticals has agreed to help Alrise Biosystems develop its drug delivery technology in its latest encapsulation-focused agreement.

Shire success will support polysialic acid drug delivery platform, says Xenetic

06-Apr-2017 - Xenetic Biosciences says success for Shire’s haemophilia A candidate SHP656 will validate its PolyXen drug delivery technology platform and could net the firm up to $100m.

US FDA accepts Evoke's CMC and PK trial plan for nasal metoclopramide

05-Apr-2017 - The US FDA has accepted a manufacturing and trial plan for Evoke Pharma's Gimoti, the nasal metoclopramide formulation that fell short in a Phase III trial last year.

US FDA hits Indoco with warning due to leaky glaucoma drug

05-Apr-2017 - Leakage problems for of an ophthalmic drug has landed contract manufacturer Indoco Remedies with a US FDA warning letter at its plant in Goa.

Emisphere set to benefit as Novo Nordisk pushes oral diabetes pipeline

30-Mar-2017 - Novo Nordisk’s focus on developing oral versions of semaglutide and four other diabetes drugs could net drug delivery firm Emisphere over $200m.

Mylan confirms plan to close Meda Soma plant in Illinois

28-Mar-2017 - Mylan will close a manufacturing site in Decatur, Illinois that it gained when it bought Swedish drug maker Meda last year.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation